US ophthalmic gene therapy company Beacon Therapeutics, which is focused on restoring the vision of patients with blinding ...

UK pharma major GSK has appointed Sanjay Gurunathan as senior vice president and global head vaccines and infectious disease ...

Shares in US pharma giant Merck & Co (NYSE: MRK) were nearly 2% higher in early trading Monday.

Shares of Avidity Biosciences (Nasdaq: RNA) were up almost 5% at $38.00 pre-market today, as it announced the accelerated ...

Swiss skincare specialist Galderma has announced two-year data from a new interim analysis of a long-term extension study ...

South Korea’s biosimilar drug developer Samsung Bioepis has announced that the company has entered into a license, ...

As Denmark presses ahead with a major health reform, a coalition of rare disease advocates and clinicians is urging the ...

George Medicines, a late-stage UK-based biopharmaceutical company focused on addressing unmet needs in cardiometabolic ...

Privately-held Italian pharma company Italfarmaco today revealed that the European Commission (EC) has granted conditional ...

French pharma major Sanofi (Euronext: SAN) has started early global shipments of its monoclonal antibody Beyfortus ...

France-based SparingVision, a genomic medicine company focused on the treatment of retinal disease, has announced the appointment of Kalliopi ‘Kali’ Stasi, as chief medical officer, effective ...

Knight will have the exclusive rights to distribute, promote, market and sell the products in Canada, and said it will begin ...